Shares of personalized health and benefits solutions provider Accolade, Inc. (ACCD) are up more than 17% Friday morning after reporting robust revenue growth in the first quarter.
Revenue for the first quarter increased 44% year-on-year to $85.5 million from $59.5 million.
Net loss, however, widened to $342.82 million or $4.92 per share from $48.71 million or $0.84 per share a year ago, as the company had goodwill impairment charges of 299.71 million in the latest quarter.
Looking forward, the company expects second-quarter revenue to be between $82 million and $83.5 million
For the full year, Accolade has raised the lower end of the revenue outlook, now expecting between $355 million and $365 million from the previous view of $350 million-$365 million.
ACCD, currently at $8.68, has traded in the range of $4.61-$55.47 in the past 52 weeks.
For comments and feedback contact: editorial@rttnews.com
Business News
April 10, 2026 16:21 ET Inflation data from the U.S. was the main data event this week as the conflict in the Middle East continue. The minutes of the latest Fed policy session and the survey data on the services sector also made headlines. In Europe, manufacturing orders data from Germany was in focus. Price data from China drew attention in Asia.